DaVita (BSP:DVAI34) Change In Payables And Accrued Expense : R$127 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is DaVita Change In Payables And Accrued Expense?

DaVita's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was R$298 Mil. It means DaVita's Accounts Payable & Accrued Expense increased by R$298 Mil from Sep. 2023 to Dec. 2023 .

DaVita's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was R$132 Mil. It means DaVita's Accounts Payable & Accrued Expense increased by R$132 Mil from Dec. 2022 to Dec. 2023 .

DaVita Change In Payables And Accrued Expense Historical Data

The historical data trend for DaVita's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Change In Payables And Accrued Expense Chart

DaVita Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

-346.99

191.38

-171.46

458.87

131.76

DaVita Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															254.98	-106.96	-97.46	33.48	297.55

DaVita Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$127 Mil.

DaVita Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of DaVita's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

DaVita (BSP:DVAI34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (BSP:DVAI34) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

DVA:USA TRL:Germany

Address

2000 16th Street, Denver, CO, USA, 80202

Website

https://www.davita.com

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

DaVita (BSP:DVAI34) Headlines

No Headlines